LEXIVA (REMEDYREPACK INC.)
Welcome to the PulseAid listing for the LEXIVA drug offered from REMEDYREPACK INC.. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A4 Inducers [MoA],P-Glycoprotein Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | REMEDYREPACK INC. |
| NON-PROPRIETARY NAME: | fosamprenavir calcium |
| SUBSTANCE NAME: | FOSAMPRENAVIR CALCIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A4 Inducers [MoA],P-Glycoprotein Inducers [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-11-11 |
| END MARKETING DATE: | 0000-00-00 |
LEXIVA HUMAN PRESCRIPTION DRUG Details:
| Item Description | LEXIVA from REMEDYREPACK INC. |
| LABELER NAME: | REMEDYREPACK INC. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 700(mg/1) |
| START MARKETING DATE: | 2011-11-11 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 49349-811_401a0d22-10e7-02ac-e054-00144ff88e88 |
| PRODUCT NDC: | 49349-811 |
| APPLICATION NUMBER: | NDA021548 |
Other FOSAMPRENAVIR CALCIUM Pharmaceutical Manufacturers / Labelers:
